We are live on
!
Find out more
HF
HRT Financial Portfolio holdings
AUM
$40.1B
1-Year Est. Return
58.22%
This Fund
S&P 500
This Quarter
Est. Return
+8.17%
1 Year Est. Return
+58.22%
3 Year Est. Return
+133.11%
5 Year Est. Return
+158.39%
10 Year Est. Return
+582.81%
AUM
$19.4B
AUM Growth
-$763M
(-3.8%)
Cap. Flow
-$1.22B
Cap. Flow
% of AUM
-6.3%
Top 10 Holdings %
Top 10 Hldgs %
44.78%
Holding
3,509
New
1,167
Increased
475
Reduced
708
Closed
1,145
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$349M |
| 2 |
Chevron
CVX
|
+$242M |
| 3 |
Applovin
APP
|
+$223M |
| 4 |
Meta Platforms (Facebook)
META
|
+$217M |
| 5 |
GE Vernova
GEV
|
+$146M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$883M |
| 2 |
Microsoft
MSFT
|
+$533M |
| 3 |
NVIDIA
NVDA
|
+$459M |
| 4 |
Eli Lilly
LLY
|
+$167M |
| 5 |
PG&E
PCG
|
+$153M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.04% |
| 2 | Financials | 6.81% |
| 3 | Communication Services | 6.52% |
| 4 | Industrials | 5.9% |
| 5 | Consumer Discretionary | 5.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2101
Mobix Labs
MOBX
$26M
| $53K | ﹤0.01% |
+3,174
| New | +$32.3K |
|
2102
PepGen
PEPG
$197M
| $53K | ﹤0.01% |
+14,080
| New | +$87.8K |
|
|
DHY
2103
Credit Suisse High Yield Credit Fund
DHY
$240M
| $52K | ﹤0.01% |
+24,489
| New | +$53.7K |
|
2104
ICL Group
ICL
$6.85B
| $51K | ﹤0.01% |
+10,525
| New | +$47.1K |
|
|
MGF
2105
Aberdeen Government Markets Income Fund
MGF
$92.2M
| $51K | ﹤0.01% |
+16,635
| New | +$52.6K |
|
|
NEWP
2106
New Pacific Metals
NEWP
$1.17B
| $51K | ﹤0.01% |
+43,290
| New | +$67.5K |
|
|
TSI
2107
TCW Strategic Income Fund
TSI
$213M
| $51K | ﹤0.01% |
+10,656
| New | +$53.5K |
|
2108
CALL
2x Long VIX Futures ETF
UVIX
$220M
| $51K | ﹤0.01% |
+76
| New | +$64.7K |
|
2109
Verrica Pharmaceuticals
VRCA
$87.3M
| $51K | ﹤0.01% |
7,286
+2,438
| +50% | +$26.8K |
|
|
SLRN
2110
DELISTED
ACELYRIN
SLRN
| $50K | ﹤0.01% |
16,021
-78,784
| -83% | -$381K |
|
2111
BlackBerry
BB
$5.26B
| $49K | ﹤0.01% |
13,078
-146,455
| -92% | -$389K |
|
|
ONL
2112
Orion Office REIT
ONL
$160M
| $49K | ﹤0.01% |
13,261
-34,738
| -72% | -$137K |
|
2113
Companhia Siderúrgica Nacional
SID
$1.23B
| $49K | ﹤0.01% |
34,646
+12,615
| +57% | +$24.7K |
|
2114
Fate Therapeutics
FATE
$326M
| $48K | ﹤0.01% |
29,173
-179,971
| -86% | -$453K |
|
2115
Lucid Diagnostics
LUCD
$184M
| $48K | ﹤0.01% |
+59,640
| New | +$52.6K |
|
|
BNKK
2116
Bonk Inc
BNKK
$8.4M
| $48K | ﹤0.01% |
+1,909
| New | +$65.8K |
|
2117
BuzzFeed
BZFD
$96.7M
| $47K | ﹤0.01% |
+17,863
| New | +$56.1K |
|
2118
Jowell Global
JWEL
$3.68M
| $47K | ﹤0.01% |
+16,634
| New | +$38.7K |
|
|
IVAC
2119
DELISTED
Intevac Inc
IVAC
| $47K | ﹤0.01% |
+13,997
| New | +$44.2K |
|
2120
BARK
BARK
$101M
| $46K | ﹤0.01% |
+1,263
| New | +$44.3K |
|
|
BGDE
2121
Big Digital Energy Inc
BGDE
$32M
| $46K | ﹤0.01% |
+2,770
| New | +$80.7K |
|
|
BCLI
2122
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $45K | ﹤0.01% |
+20,022
| New | +$37K |
|
|
MSPR
2123
DELISTED
MSP Recovery Inc
MSPR
| $45K | ﹤0.01% |
+2,859
| New | +$52.1K |
|
|
ADAP
2124
DELISTED
Adaptimmune Therapeutics
ADAP
| $44K | ﹤0.01% |
+83,199
| New | +$60.6K |
|
|
MBAI
2125
Check-Cap
MBAI
$10.9M
| $44K | ﹤0.01% |
+44,644
| New | +$47.3K |
|
Similar funds
DB
HRT Financial's Q4 2024 Portfolio in Review
As of Q4 2024, HRT Financial held 3,509 positions worth $19.4B, down 3.8% from $20.1B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
HRT Financial withdrew a net $1.22B in Q4 2024, closing 1,145 positions and reducing 708 holdings. Its most notable exit was PG&E, an estimated $153M position sold in full.
By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 11% a quarter earlier, followed by Financials and Communication Services.
Against the trend, HRT Financial opened a new position in Broadcom worth $437M.
- HRT Financial's largest Q4 2024 buy was Broadcom: 1,884,640 shares worth $437M.
- HRT Financial added most to Meta Platforms (Facebook) in Q4 2024, an estimated $217M increase.
- HRT Financial's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $883M.
- HRT Financial fully exited PG&E in Q4 2024, selling an estimated $153M.
- HRT Financial's ten largest holdings make up 45% of its $19.4B portfolio in Q4 2024.
- HRT Financial opened 1,167 new positions and closed 1,145 in Q4 2024.
- HRT Financial's portfolio value fell 3.8% quarter-over-quarter to $19.4B.
Based on HRT Financial's 13F filing for Q4 2024, filed 14 Feb 2025.